Schilke Tobin

CIK 0001678984

CFO

Filings

4

Latest Mar 19, 2024

Issuers covered

1

Showing

4 of 4

Page 1

Issuers

Companies where Schilke Tobin has filed

TickerIssuerFilingsLast filed
RVNCRevance Therapeutics, Inc.4Mar 19, 2024

All filings

4 Form 4 / 4-A filings, newest first

FiledIssuerTop transactionSharesPriceValue
Mar 19, 2024RVNCRevance Therapeutics, Inc.S9,361$5.0426$47,204
Mar 4, 2024RVNCRevance Therapeutics, Inc.A17,447$0.00$0
Feb 2, 2024RVNCRevance Therapeutics, Inc.A96,667$0.00$0
Jan 3, 2024RVNCRevance Therapeutics, Inc.A434$7.47$3,242

Showing 14 of 4

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.